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Abstract: Use of topical steroids is an important component of postoperative care after 
ﬁ  ltration surgery. Efﬁ  cacy of postoperative medications is affected by patient adherence and 
physical limitations in the elderly population often prohibit proper dosing of ophthalmic drops. 
We describe a technique for the use of intraoperative retrobulbar triamcinolone acetonide in 
trabeculectomy surgery and report on postoperative outcomes. This technique appears safe and 
may be an attractive method of delivering a steroid depot at the time of trabeculectomy.
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Introduction
Antiﬁ  brotic medications augment the success of trabeculectomy procedures by decreas-
ing ﬁ  broblast proliferation and scar formation. In particular, Mitomycin C (MMC) 
acts as an alkylating agent and inhibits DNA-dependent RNA synthesis leading to 
decreased ﬁ  broblast proliferation. MMC also has direct toxic effects on proliferating 
and nonproliferating cells causing cell apoptosis.1,2 Despite the improved success rate 
of antiﬁ  brotic-assisted trabeculectomy, many cases fail due to persistent inﬂ  ammation, 
scar formation, and eventual loss of intraocular pressure (IOP) control.3
The use of steroid drops postoperatively has been shown to increase the success rate 
of trabeculectomy surgery.4 Using drops requires a great deal of patient cooperation 
and instillation can be difﬁ  cult in those with already impaired vision and/or physical 
limitations. We performed consecutive trabeculectomy procedures with MMC and 
retrobulbar triamcinolone acetonide (RTA) in patients considered at high risk of failure 
due to previous unsuccessful glaucoma surgery.
Methods
This is a retrospective review of trabeculectomy procedures performed between July 
2005 and January 2006 using intraoperative MMC and RTA. All surgeries were done 
using fornix based conjunctival incisions and MMC (0.2 mg/ml for 2 minutes). RTA 
(20 mg in 0.5 ml) was deposited in the retrobulbar space using a blunt cannula attached 
to a 5 ml syringe followed by conjunctival closure (Figures 1 and 2). Postoperative 
drop regimen consisted of prednisolone acetate 1%, fourth generation ﬂ  uoroquinolone, 
and atropine 1% each four times per day. Data collected included age, preoperative 
diagnosis, number of pre- and postoperative medications, pre- and postoperative IOP, 
and complication rates. Success was deﬁ  ned as IOP  5 and 21 mm Hg without 
need for further medications or surgical intervention. Analysis of variance was used 
to compare statistical signiﬁ  cance between pre- and postoperative IOP values.
Results
Information was available from 14 consecutive cases, eight women and six men, under-
going trabeculectomy with MMC and RTA. Mean age was 66.93 ± 14.51 years with Clinical Ophthalmology 2009:3 30
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visual acuity ranging between 20/20 and 20/100. Preoperative 
diagnosis included 12 patients with primary open angle 
glaucoma, one with uveitic glaucoma, and one with con-
genital glaucoma. Thirteen patients had failed previous 
trabeculectomy with MMC and one had previous goniotomy 
at six months of age. Mean preoperative hypotensive drop 
use was 3.0 ± 0.68.
IOP decreased from a preoperative level of 26.43 ± 8.32 to 
10.64 ± 1.82 at six months (p  0.001). The decrease in IOP 
was statistically signiﬁ  cant at all time points (Table 1) and 
all patients remained off hypotensive drops for the duration 
of follow up. Three patients lost one line of vision attributed 
to cataract progression while the remaining 11 patients 
experienced no change in visual acuity. The patient with 
uveitic glaucoma was considered a treatment failure after IOP 
increased to 22 mm Hg three months post-operatively. He 
required a bleb needling procedure with MMC and remains 
off hypotensive drops with an IOP of 8 after six months of 
follow-up. There were no cases of postoperative bleb leak, 
infection, hypotony or conjunctival ulceration.
Discussion
Pre- and postoperative use of steroids has been reported in 
patients undergoing trabeculectomy.4,5 Araujo and colleagues 
reported on the effects of postoperative corticosteroids on IOP 
and clinical course.4 They found that patients who received 
postoperative steroids were less likely to have higher IOP’s, 
less likely to need further glaucoma surgery, and required 
less glaucoma medicines for IOP control. Giangiacomo and 
colleagues reported the use of subconjunctival triamcinolone 
acetonide injected prior to surgery in 15 eyes of patients 
considered to be at increased risk for postoperative scarring.5 
All eyes were followed for six to 16 months with fourteen 
considered successfully controlled with an IOP of 12.4 ± 4.6 
and only three of the 14 eyes required antiglaucoma medica-
tions. Tham and colleagues reported on the intraoperative 
subconjunctival injection of triamcinolone acetonide using a 
27-gauge needle in 11 patients. Results showed this method 
to be compatible with successful clinical outcomes.6
Figure 1 Triamcinolone acetonide is injected using a blunt cannula prior to conjunctival 
closure. The cannula is inserted in the hub and the steroid depot is injected in the 
retrobulbar space.
Figure 2 Two interrupted 9-0 vicryl sutures reapproximate the conjunctiva at the 
end of the case.
Table 1 Pre- and postoperative intraocular pressure in patients 
receiving retrobulbar triamcinolone acetonide at time of trabecu-
lectomy
IOP (n = 14) Mean and standard 
deviation (mm Hg)
Preoperative IOP 26.43 ± 8.32
POD 1 IOP 11.36 ± 3.67
POD 7 IOP 9.86 ± 3.42
POD 30 IOP 11.07 ± 2.40
POD 90 IOP 10.42 ± 2.71
POD 180 IOP 10.64 ± 1.82
Note: *Change in IOP from baseline was statistically signiﬁ  cant (p  0.001) at all 
time points.
Abbreviations: IOP, intraocular pressure; POD, postoperative day.Clinical Ophthalmology 2009:3 31
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The success rate, as deﬁ  ned in this study, was 93% 
(13/14 patients) with six months of follow-up. All patients 
experienced a decrease in IOP without the use of hypotensive 
glaucoma drops. The use of RTA in trabeculectomy with 
MMC appears safe in a patient population considered at high 
risk of failure and resulted in well-functioning diffuse blebs. 
The use of a cannula decreases the risk associated with use of 
a needle to inject steroids either pre-, peri-, or postoperatively 
and assures that steroids will reach the site of ﬁ  ltration inde-
pendent of adherence to drop therapy. In contrast to injection 
of steroids adjacent to the bleb at the end of surgery using a 
needle, our technique allows for the medication to come in 
direct contact with the bleb surface without creation of an 
unnecessary conjunctival hole. Further studies will be needed, 
in a prospective and randomized fashion, to better delineate 
the utility of retrobulbar steroids combined with MMC in 
increasing the efﬁ  cacy of trabeculectomy procedures.
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